| __timestamp | Agios Pharmaceuticals, Inc. | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 19120000 | 7751000 |
| Thursday, January 1, 2015 | 35992000 | 10251000 |
| Friday, January 1, 2016 | 50714000 | 9575000 |
| Sunday, January 1, 2017 | 71124000 | 10912000 |
| Monday, January 1, 2018 | 114145000 | 11049000 |
| Tuesday, January 1, 2019 | 132034000 | 11646000 |
| Wednesday, January 1, 2020 | 149070000 | 13265000 |
| Friday, January 1, 2021 | 121445000 | 25805000 |
| Saturday, January 1, 2022 | 121673000 | 35182000 |
| Sunday, January 1, 2023 | 119903000 | 94999000 |
| Monday, January 1, 2024 | 156784000 |
Infusing magic into the data realm
In the competitive world of biotechnology, operational efficiency is key. Agios Pharmaceuticals, Inc. and Viridian Therapeutics, Inc. offer a fascinating study in contrasts when it comes to Selling, General, and Administrative (SG&A) expenses. Over the past decade, Agios has consistently outpaced Viridian, with its SG&A expenses peaking at nearly 150% higher than Viridian's in 2020. However, Viridian has shown a remarkable upward trend, with a staggering 800% increase in SG&A expenses from 2014 to 2023. This surge reflects Viridian's aggressive expansion and strategic investments. Meanwhile, Agios's expenses have stabilized, indicating a mature operational strategy. As of 2023, the gap has narrowed significantly, with Viridian's expenses reaching 80% of Agios's. This shift highlights the dynamic nature of the biotech industry, where strategic financial management can redefine competitive landscapes.
Novo Nordisk A/S vs Agios Pharmaceuticals, Inc.: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Zoetis Inc. and Viridian Therapeutics, Inc.
Breaking Down SG&A Expenses: BioMarin Pharmaceutical Inc. vs Viridian Therapeutics, Inc.
Ascendis Pharma A/S vs Viridian Therapeutics, Inc.: SG&A Expense Trends
Pharming Group N.V. or Viridian Therapeutics, Inc.: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: Lantheus Holdings, Inc. vs Viridian Therapeutics, Inc.
Comparing SG&A Expenses: TG Therapeutics, Inc. vs Viridian Therapeutics, Inc. Trends and Insights
Viking Therapeutics, Inc. or Viridian Therapeutics, Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of Ligand Pharmaceuticals Incorporated and Agios Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Agios Pharmaceuticals, Inc. and MannKind Corporation
Breaking Down SG&A Expenses: Agios Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.
Selling, General, and Administrative Costs: Galapagos NV vs Viridian Therapeutics, Inc.